Simplify High Yield ETFCDX

The Simplify high-return ETF, ticker CDX, is listed on Nasdaq and promises exposure to high-return US corporate bonds under the banner of “strategic income.” The fund’s mandate is straightforward: track the ICE BofA US high-return Index, a benchmark that includes bonds rated below investment grade and updated monthly to reflect the shifting environment of credit risk. In practice, CDX is a fee-driven wrapper around a portfolio of corporate bonds where the issuer extracts a management fee while the underlying bonds do the work of generating yield. The fund’s presence on Nasdaq means it trades like any other ETF, subject to the same liquidity and spread dynamics as its equity cousins, notwithstanding its fixed-income roots.

What CDX actually holds is determined by the index rules, which dictate inclusion based on rating, liquidity, and maturity. The fund’s holdings are not static; they rotate as bonds migrate between rating tiers or as new issuance enters the index. The issuer’s marketing material will lean into themes like “high income” or “diversified credit exposure,” but the reality is a portfolio of corporate bonds where the yield after fees is the only number that ultimately matters to investors. The fund’s expense ratio sits at 0.45%, a figure that quietly erodes the gross yield the bonds generate, a fact that rarely features in the polished brochures.

SEC filings for CDX are available on EDGAR, where the fund’s registration statements and periodic reports sit like unread manuals in a drawer. These filings confirm the fund’s structure, fees, and investment objectives but provide no insight into the bonds’ performance beyond the index’s published returns. The filings do not disclose the bonds’ individual yields, default rates, or recovery assumptions, leaving investors to rely on the index’s aggregate data and the issuer’s fee schedule. The fund’s AUM and liquidity metrics are not highlighted in EDGAR, nor are they quantified in the source evidence; what we know is that CDX trades on Nasdaq, which implies a minimum level of liquidity but does not quantify it.

The fund’s tracking method is index replication, meaning it aims to mirror the ICE BofA US high-return Index’s holdings and returns. The index itself is a market-value-weighted basket, updated monthly, and rebalanced at month-end. The fund’s ability to track the index depends on its holdings matching the index’s constituents and the issuer’s operational efficiency in managing the portfolio. There is no evidence supplied that the fund relative strength or lag the index by a material margin after fees, nor is there data on the fund’s tracking error. The fund’s presence on Nasdaq is the primary evidence of its market accessibility, but Nasdaq’s data does not provide a live feed of the fund’s holdings or its real-time tracking accuracy.

What changed this week: CDX’s presence on Nasdaq is unchanged, with no new listings, delistings, or material updates to its mandate or fees reported in the source evidence. The fund’s holdings and performance remain tied to the ICE BofA US high-return Index, which updates monthly; any changes to the index’s constituents will flow through to the fund’s portfolio, but the source evidence does not provide a schedule of upcoming index changes. The fund’s expense ratio and fees are unchanged, and no new filings or amendments to the fund’s registration statements have been supplied in the source evidence. The fund’s AUM and liquidity are not quantified in the source evidence, and no new disclosures on these metrics have been supplied.